Hypertension with Left Ventricular Hypertrophy
📧 Sign up to get email alerts when something new happens for Hypertension with Left Ventricular Hypertrophy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-10-03FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Losartan Potassium from Unichem Pharmaceuticals (USA), Inc. under ANDA 203030.
-
FDA approval · 2022-07-01FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium from Aurobindo Pharma Limited, authorizing changes to the approved ANDA.